Global Tonic-Clonic Seizures Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 104

Report ID: 2068

Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic–clonic seizures are a type of generalized seizures, which affect the entire brain and are the most common type of epileptic seizures. Grand mal seizures are caused by neurotransmitter imbalances, which can also be influenced by fatigue, lack of sleep, hypertension, stress, intense lighting, rapid motion, blood sugar level, anxiety, etc. The grand mal seizures consist of two phases, the tonic phase and the clonic phase. The tonic phase involves loss of consciousness and muscle twitching and the phase usually last only for a few seconds. The clonic phase consists of rapid muscle contraction and relaxation resulting in convulsions.
The Americas accounts for the significant market share owing to extensive use of medications and greater expenditure on the health care. Additionally, the fastest uptake of new technology and drugs in the US drives the global grand mal seizures market. The concentration of the major medical diagnostic device manufacturers in the developed regions is also adding fuel to the market. Europe is the second largest market due to a high disposable income and rising awareness about the grand mal seizures.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead the market during the forecast period.
In 2018, the global Tonic-Clonic Seizures market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Tonic-Clonic Seizures status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tonic-Clonic Seizures development in United States, Europe and China.

The key players covered in this study
Pfizer
Johnson & Johnson
UCB Celltech
Abbott Laboratories
GlaxoSmithKline
Novartis
Sanofi
Shire
Teva Pharmaceutical

Market segment by Type, the product can be split into
Barbiturates
Hydantoin
Phenyltriazine
Iminostilbenes
Benzodiazepines
Aliphatic Carboxylic Acid
Others

Market segment by Application, split into
Hospitals
Clinics
Academic and Research Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Tonic-Clonic Seizures status, future forecast, growth opportunity, key market and key players.
To present the Tonic-Clonic Seizures development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Tonic-Clonic Seizures are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tonic-Clonic Seizures Market Size Growth Rate by Type (2014-2025)
1.4.2 Barbiturates
1.4.3 Hydantoin
1.4.4 Phenyltriazine
1.4.5 Iminostilbenes
1.4.6 Benzodiazepines
1.4.7 Aliphatic Carboxylic Acid
1.4.8 Others
1.5 Market by Application
1.5.1 Global Tonic-Clonic Seizures Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Academic and Research Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Tonic-Clonic Seizures Market Size
2.2 Tonic-Clonic Seizures Growth Trends by Regions
2.2.1 Tonic-Clonic Seizures Market Size by Regions (2014-2025)
2.2.2 Tonic-Clonic Seizures Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Tonic-Clonic Seizures Market Size by Manufacturers
3.1.1 Global Tonic-Clonic Seizures Revenue by Manufacturers (2014-2019)
3.1.2 Global Tonic-Clonic Seizures Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Tonic-Clonic Seizures Market Concentration Ratio (CR5 and HHI)
3.2 Tonic-Clonic Seizures Key Players Head office and Area Served
3.3 Key Players Tonic-Clonic Seizures Product/Solution/Service
3.4 Date of Enter into Tonic-Clonic Seizures Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Tonic-Clonic Seizures Market Size by Type (2014-2019)
4.2 Global Tonic-Clonic Seizures Market Size by Application (2014-2019)

5 United States
5.1 United States Tonic-Clonic Seizures Market Size (2014-2019)
5.2 Tonic-Clonic Seizures Key Players in United States
5.3 United States Tonic-Clonic Seizures Market Size by Type
5.4 United States Tonic-Clonic Seizures Market Size by Application

6 Europe
6.1 Europe Tonic-Clonic Seizures Market Size (2014-2019)
6.2 Tonic-Clonic Seizures Key Players in Europe
6.3 Europe Tonic-Clonic Seizures Market Size by Type
6.4 Europe Tonic-Clonic Seizures Market Size by Application

7 China
7.1 China Tonic-Clonic Seizures Market Size (2014-2019)
7.2 Tonic-Clonic Seizures Key Players in China
7.3 China Tonic-Clonic Seizures Market Size by Type
7.4 China Tonic-Clonic Seizures Market Size by Application

8 Japan
8.1 Japan Tonic-Clonic Seizures Market Size (2014-2019)
8.2 Tonic-Clonic Seizures Key Players in Japan
8.3 Japan Tonic-Clonic Seizures Market Size by Type
8.4 Japan Tonic-Clonic Seizures Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Tonic-Clonic Seizures Market Size (2014-2019)
9.2 Tonic-Clonic Seizures Key Players in Southeast Asia
9.3 Southeast Asia Tonic-Clonic Seizures Market Size by Type
9.4 Southeast Asia Tonic-Clonic Seizures Market Size by Application

10 India
10.1 India Tonic-Clonic Seizures Market Size (2014-2019)
10.2 Tonic-Clonic Seizures Key Players in India
10.3 India Tonic-Clonic Seizures Market Size by Type
10.4 India Tonic-Clonic Seizures Market Size by Application

11 Central & South America
11.1 Central & South America Tonic-Clonic Seizures Market Size (2014-2019)
11.2 Tonic-Clonic Seizures Key Players in Central & South America
11.3 Central & South America Tonic-Clonic Seizures Market Size by Type
11.4 Central & South America Tonic-Clonic Seizures Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Tonic-Clonic Seizures Introduction
12.1.4 Pfizer Revenue in Tonic-Clonic Seizures Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Tonic-Clonic Seizures Introduction
12.2.4 Johnson & Johnson Revenue in Tonic-Clonic Seizures Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 UCB Celltech
12.3.1 UCB Celltech Company Details
12.3.2 Company Description and Business Overview
12.3.3 Tonic-Clonic Seizures Introduction
12.3.4 UCB Celltech Revenue in Tonic-Clonic Seizures Business (2014-2019)
12.3.5 UCB Celltech Recent Development
12.4 Abbott Laboratories
12.4.1 Abbott Laboratories Company Details
12.4.2 Company Description and Business Overview
12.4.3 Tonic-Clonic Seizures Introduction
12.4.4 Abbott Laboratories Revenue in Tonic-Clonic Seizures Business (2014-2019)
12.4.5 Abbott Laboratories Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Tonic-Clonic Seizures Introduction
12.5.4 GlaxoSmithKline Revenue in Tonic-Clonic Seizures Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Tonic-Clonic Seizures Introduction
12.6.4 Novartis Revenue in Tonic-Clonic Seizures Business (2014-2019)
12.6.5 Novartis Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Tonic-Clonic Seizures Introduction
12.7.4 Sanofi Revenue in Tonic-Clonic Seizures Business (2014-2019)
12.7.5 Sanofi Recent Development
12.8 Shire
12.8.1 Shire Company Details
12.8.2 Company Description and Business Overview
12.8.3 Tonic-Clonic Seizures Introduction
12.8.4 Shire Revenue in Tonic-Clonic Seizures Business (2014-2019)
12.8.5 Shire Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Tonic-Clonic Seizures Introduction
12.9.4 Teva Pharmaceutical Revenue in Tonic-Clonic Seizures Business (2014-2019)
12.9.5 Teva Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details